A recent study from scientists at the Garvan Institute of Medical Research has uncovered an important clue about why some people with leukemia also develop autoimmune diseases.
These are conditions where the body’s immune system mistakenly attacks its own healthy tissues. The research shows that certain gene changes linked to leukemia can create “rogue” immune cells that behave abnormally and may trigger these diseases.
The immune system is designed to protect the body. It uses many different types of cells to find and destroy harmful invaders such as viruses, bacteria, and even cancer cells. One important group of these cells is called T cells. Among them are “killer T cells,” which are responsible for attacking and removing infected or abnormal cells.
In a healthy person, killer T cells are tightly controlled. They grow, act, and stop at the right time. This balance is important because it allows the immune system to defend the body without causing damage. However, when something goes wrong, these cells can become overactive or behave in unpredictable ways.
The new research shows that changes in certain genes can disturb this balance. These gene changes are often seen in leukemia, a type of blood cancer. The scientists found that these changes can affect how a key protein works inside immune cells. This protein, known as STAT3, plays a major role in controlling how immune cells grow and respond.
To better understand this process, the researchers studied blood samples from children who had rare inherited autoimmune diseases. These cases are especially useful for research because they often involve clear genetic causes. The scientists then used a powerful gene-editing tool called CRISPR to change the STAT3 protein in laboratory models.
CRISPR allows scientists to make very precise changes to genes, helping them see how those changes affect cells. In this study, altering STAT3 had a strong effect on killer T cells. The cells became larger, more active, and harder to control. They were able to bypass the usual safety checks that stop immune cells from attacking the body.
What surprised the researchers was how small the change needed to be to cause a problem. Even when only one to two percent of the T cells became “rogue,” it was enough to trigger an autoimmune reaction. This shows how sensitive the immune system is and how even a small group of abnormal cells can have a large impact.
This discovery helps explain why people with leukemia sometimes develop autoimmune conditions such as rheumatoid arthritis or aplastic anemia. It suggests that the same genetic changes that affect cancer development may also disrupt the immune system in other ways.
The study also found that certain cell receptors linked to stress responses may play a role in this process. These receptors can influence how immune cells react to signals in the body, adding another layer of complexity to how autoimmune diseases develop.
These findings could have important benefits for patients in the future. By understanding how rogue immune cells form, doctors may be able to better predict who is at risk of developing autoimmune diseases. This could lead to earlier diagnosis and more targeted treatment.
For example, some medications, such as JAK inhibitors, already target pathways related to STAT3. With more knowledge about a patient’s genetic makeup, doctors may be able to choose treatments that are more effective and have fewer side effects.
In the long term, researchers hope to develop new screening methods that can detect these rogue cells early. By analyzing a simple blood sample and studying the genetic information of individual cells, doctors may be able to identify problems before symptoms appear.
This kind of personalized approach to medicine could make treatment safer and more precise. It could also help prevent disease rather than simply treating it after it has already developed.
The study was led by Dr. Etienne Masle-Farquhar and published in the journal Immunity. It represents an important step forward in understanding the link between cancer and autoimmune disease, and it opens the door to new ways of protecting the body from both.
If you care about cancer, please read studies that low-carb diet could increase overall cancer risk, and new way to increase the longevity of cancer survivors.
For more health information, please see recent studies about how to fight cancer with these anti-cancer superfoods, and results showing daily vitamin D3 supplementation may reduce cancer death risk.
Copyright © 2026 Knowridge Science Report. All rights reserved.
